GlassScriptPhysician profile
Meredith Cindi Levine
NPI 1922275957
$26,164.56
in general payments reported to CMS, 2019-2025
20 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,341 · 2020: $328 · 2021: $4,773 · 2022: $6,187 · 2023: $8,512 · 2024: $2,921 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $11K · Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $11,000.00 |
| Food and Beverage | $536.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $21,038.63 | 2021-2024 | Nexplanon |
| Merck Sharp & Dohme LLC | $3,168.83 | 2019-2024 | Gardasil, Capvaxive, Gardasil 9 |
| Abbvie INC. | $791.90 | 2019-2022 | |
| Coopersurgical, INC. | $207.72 | 2021-2025 | Paragard T 380a, Paragard T 380a |
| Aspira Women'S Health INC | $162.71 | 2022-2023 | Ova1 |
| Astellas Pharma US INC | $116.02 | 2023-2024 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $101.29 | 2019-2022 | |
| Agile Therapeutics, INC. | $100.16 | 2021-2023 | Twirla |
| Hologic Sales and Service, LLC | $92.16 | 2022-2025 | Thinprep 2000 Processor, Aptima |
| Medtronic, INC. | $72.65 | 2021 | |
| Roche Diagnostics Corporation | $68.52 | 2019-2021 | |
| Therapeuticsmd, INC. | $49.75 | 2019-2022 | |
| Teleflex LLC | $49.67 | 2025 | Quikclot |
| Ethicon US, LLC | $35.64 | 2020-2021 | |
| Avion Pharmaceuticals | $26.27 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $18.43 | 2024 | |
| Exeltis, USA INC. | $17.58 | 2024 | Slynd |
| Mayne Pharma Commercial LLC | $16.95 | 2023 | |
| Shield Therapeutics INC | $15.10 | 2025 | |
| Evofem Biosciences, INC. | $14.58 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Levine listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.